The decrease in NKG2D+ Natural Killer cells in peripheral blood of patients with metastatic colorectal cancer

Area of Science:

• Immunology
• Oncology

Background:

• Natural killer (NK) cells are vital for immune defense against colorectal cancer.
• NKG2D is an activating immune receptor found on NK and CD8+ T cells.
• Investigating NKG2D expression in colorectal cancer patients is crucial for understanding immune evasion.

Purpose of the Study:

• To investigate the expression of the NKG2D molecule in peripheral blood NK cells of colorectal cancer patients.
• To compare NKG2D expression levels between colorectal cancer patients and healthy subjects.

Main Methods:

• Studied 21 non-metastatic (low-grade), 17 non-metastatic (high-grade), 16 metastatic colorectal cancer patients, and 24 healthy controls.
• Analyzed NKG2D+CD3-CD56+ NK cells percentage using flow cytometry.
• Measured NKG2D mRNA expression via real-time PCR.

Main Results:

• A significant reduction in NKG2D+NK cells percentage was observed in metastatic colorectal cancer patients.
• NKG2D mRNA expression was also significantly decreased in the peripheral blood of metastatic colon cancer patients.

Conclusions:

• Decreased NKG2D receptor expression in metastatic colorectal cancer may impair NK cell function.
• This reduction could allow tumors to evade immune surveillance.
• Further research into NKG2D's role in colorectal cancer immunity is warranted.